Scientists study rare gene variants to unlock secrets of cholesterol and blood sugar
NCT ID NCT04234724
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how natural genetic variations in the ANGPTL3 gene affect the way the body handles fats and sugars. Researchers will compare people with these gene variants to matched controls using special tests like fat and glucose tolerance tests. The goal is to better understand the role of ANGPTL3 in metabolism, which could inform future treatments for cholesterol and diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help scientists understand how ANGPTL3 controls cholesterol and blood sugar, potentially pointing toward new treatments for high cholesterol or diabetes.
- What could go wrong
- This is an early observational study with only 50 participants, so findings may not apply broadly. It does not test any treatment, so no direct health benefit for participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States